ABI
INCY icon

Adamant Biomedical Investments’s Incyte INCY Stock Holding History

Adamant Biomedical Investments’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$5.12M Hold
70,000
– – 1.22% 29
2014
Q3 		$3.43M Buy
+70,000
New +$3.51M 0.86% 44

Other funds holding INCY

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Adamant Biomedical Investments's INCY Position: Q4 2014 in Review

Adamant Biomedical Investments held its Incyte (INCY) position steady in Q4 2014 at 70,000 shares worth $5.12M. The position accounts for 1.22% of the portfolio, ranked #29.

Adamant Biomedical Investments first reported a position in INCY in Q3 2014 and has held it in 2 quarters since. 284 funds tracked by Wall St. Rank hold INCY as of Q4 2014.

  • Adamant Biomedical Investments held 70,000 shares of Incyte worth $5.12M as of Q4 2014.
  • Adamant Biomedical Investments left its Incyte share count unchanged in Q4 2014.
  • Incyte made up 1.22% of Adamant Biomedical Investments's portfolio in Q4 2014, its #29 holding.
  • Adamant Biomedical Investments first reported a position in Incyte in Q3 2014 and has held it in 2 quarters since.
  • 284 funds tracked by Wall St. Rank held Incyte as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.